273 related articles for article (PubMed ID: 30367664)
21. Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline.
Koss DJ; Jones G; Cranston A; Gardner H; Kanaan NM; Platt B
Acta Neuropathol; 2016 Dec; 132(6):875-895. PubMed ID: 27770234
[TBL] [Abstract][Full Text] [Related]
22. Dysregulated Stem Cell Markers Musashi-1 and Musashi-2 are Associated with Therapy Resistance in Inflammatory Breast Cancer.
Haiduk TS; Sicking M; Brücksken KA; Espinoza-Sánchez NA; Eder KM; Kemper B; Eich HT; Götte M; Greve B; Troschel FM
Arch Med Res; 2023 Sep; 54(6):102855. PubMed ID: 37481823
[TBL] [Abstract][Full Text] [Related]
23. Interaction of tau with HNRNPA2B1 and N
Jiang L; Lin W; Zhang C; Ash PEA; Verma M; Kwan J; van Vliet E; Yang Z; Cruz AL; Boudeau S; Maziuk BF; Lei S; Song J; Alvarez VE; Hovde S; Abisambra JF; Kuo MH; Kanaan N; Murray ME; Crary JF; Zhao J; Cheng JX; Petrucelli L; Li H; Emili A; Wolozin B
Mol Cell; 2021 Oct; 81(20):4209-4227.e12. PubMed ID: 34453888
[TBL] [Abstract][Full Text] [Related]
24. Ectopic expression of Musashi-1 in Alzheimer disease and Pick disease.
Lovell MA; Markesbery WR
J Neuropathol Exp Neurol; 2005 Aug; 64(8):675-80. PubMed ID: 16106215
[TBL] [Abstract][Full Text] [Related]
25. (-)- Gossypol Inhibition of Musashi-Mediated Forgetting Improves Memory and Age-Dependent Memory Decline in Caenorhabditis elegans.
Mastrandreas P; Arnold A; Boglari C; de Quervain DJ; Stetak A; Papassotiropoulos A
Mol Neurobiol; 2023 Feb; 60(2):820-835. PubMed ID: 36378468
[TBL] [Abstract][Full Text] [Related]
26. Pre-synaptic C-terminal truncated tau is released from cortical synapses in Alzheimer's disease.
Sokolow S; Henkins KM; Bilousova T; Gonzalez B; Vinters HV; Miller CA; Cornwell L; Poon WW; Gylys KH
J Neurochem; 2015 May; 133(3):368-79. PubMed ID: 25393609
[TBL] [Abstract][Full Text] [Related]
27. Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer's disease.
Keck S; Nitsch R; Grune T; Ullrich O
J Neurochem; 2003 Apr; 85(1):115-22. PubMed ID: 12641733
[TBL] [Abstract][Full Text] [Related]
28. Visual cognition in non-amnestic Alzheimer's disease: Relations to tau, amyloid, and cortical atrophy.
Putcha D; Brickhouse M; Touroutoglou A; Collins JA; Quimby M; Wong B; Eldaief M; Schultz A; El Fakhri G; Johnson K; Dickerson BC; McGinnis SM
Neuroimage Clin; 2019; 23():101889. PubMed ID: 31200149
[TBL] [Abstract][Full Text] [Related]
29. Increased levels of granular tau oligomers: an early sign of brain aging and Alzheimer's disease.
Maeda S; Sahara N; Saito Y; Murayama S; Ikai A; Takashima A
Neurosci Res; 2006 Mar; 54(3):197-201. PubMed ID: 16406150
[TBL] [Abstract][Full Text] [Related]
30. Purification and Characterization of Low-n Tau Oligomers.
Kaniyappan S; Chandupatla RR; Mandelkow E
Methods Mol Biol; 2018; 1779():99-111. PubMed ID: 29886530
[TBL] [Abstract][Full Text] [Related]
31. Key Peptides and Proteins in Alzheimer's Disease.
Penke B; Bogár F; Paragi G; Gera J; Fülöp L
Curr Protein Pept Sci; 2019; 20(6):577-599. PubMed ID: 30605056
[TBL] [Abstract][Full Text] [Related]
32. Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease.
Stancu IC; Ferraiolo M; Terwel D; Dewachter I
Adv Exp Med Biol; 2019; 1184():145-166. PubMed ID: 32096036
[TBL] [Abstract][Full Text] [Related]
33. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
[TBL] [Abstract][Full Text] [Related]
34. Hsp90 activator Aha1 drives production of pathological tau aggregates.
Shelton LB; Baker JD; Zheng D; Sullivan LE; Solanki PK; Webster JM; Sun Z; Sabbagh JJ; Nordhues BA; Koren J; Ghosh S; Blagg BSJ; Blair LJ; Dickey CA
Proc Natl Acad Sci U S A; 2017 Sep; 114(36):9707-9712. PubMed ID: 28827321
[TBL] [Abstract][Full Text] [Related]
35. High molecular mass assemblies of amyloid-β oligomers bind prion protein in patients with Alzheimer's disease.
Dohler F; Sepulveda-Falla D; Krasemann S; Altmeppen H; Schlüter H; Hildebrand D; Zerr I; Matschke J; Glatzel M
Brain; 2014 Mar; 137(Pt 3):873-86. PubMed ID: 24519981
[TBL] [Abstract][Full Text] [Related]
36. Pathological Alterations of Tau in Alzheimer's Disease and 3xTg-AD Mouse Brains.
Li L; Jiang Y; Hu W; Tung YC; Dai C; Chu D; Gong CX; Iqbal K; Liu F
Mol Neurobiol; 2019 Sep; 56(9):6168-6183. PubMed ID: 30734228
[TBL] [Abstract][Full Text] [Related]
37. Evolutionary analysis of the Musashi family: What can it tell us about Zika?
Caldas-Garcia GB; Schüler-Faccini L; Pissinatti A; Paixão-Côrtes VR; Bortolini MC
Infect Genet Evol; 2020 Oct; 84():104364. PubMed ID: 32422351
[TBL] [Abstract][Full Text] [Related]
38. Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies.
Higashi S; Iseki E; Yamamoto R; Minegishi M; Hino H; Fujisawa K; Togo T; Katsuse O; Uchikado H; Furukawa Y; Kosaka K; Arai H
Brain Res; 2007 Dec; 1184():284-94. PubMed ID: 17963732
[TBL] [Abstract][Full Text] [Related]
39. The stem cell self-renewal gene, Musashi 1, is highly expressed in tumor and non-tumor samples of human bladder.
Nikpour P; Mowla SJ; Forouzandeh-Moghaddam M; Ziaee SA
Indian J Cancer; 2013; 50(3):214-8. PubMed ID: 24061461
[TBL] [Abstract][Full Text] [Related]
40. Acetylation as a major determinant to microtubule-dependent autophagy: Relevance to Alzheimer's and Parkinson disease pathology.
Esteves AR; Palma AM; Gomes R; Santos D; Silva DF; Cardoso SM
Biochim Biophys Acta Mol Basis Dis; 2019 Aug; 1865(8):2008-2023. PubMed ID: 30572013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
